- Conditions
- Internal Hemorrhoids
- Interventions
- Hydrocortisone Acetate Suppository, 25 mg (Nivagen), Placebo (Vehicle) Suppository (Nivagen)
- Drug
- Lead sponsor
- Nivagen Pharmaceuticals Inc.
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 103 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2019 – 2021
- U.S. locations
- 1
- States / cities
- Charlotte, North Carolina
Search Results
Search by objective public record fields.
Search by query text, NCT ID, condition, intervention, sponsor, city, state, recruitment status, phase, study type, healthy volunteer eligibility, sex, or age. Results are retrieved from ClinicalTrials.gov and synchronized into the directory. Search pages remain noindex by default.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Showing 25–48
of 24
matching trials from the live ClinicalTrials.gov search.
Local D1 index available.
- Conditions
- Infertility, Infertility Unexplained
- Interventions
- Flourish HEC and BioGenesis
- Combination Product
- Lead sponsor
- Vaginal Biome Science
- Other
- Eligibility
- 18 Years to 40 Years · Female only
- Enrollment
- 1 participant
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2022 – 2023
- U.S. locations
- 1
- States / cities
- San Ramon, California
- Conditions
- Kidney Transplant
- Interventions
- Infliximab, Methylprednisolone, Mycophenolate Mofetil, Tacrolimus, Thymoglobulin®, Acetaminophen, Loratadine, Placebo for Infliximab, Prednisone, Diphenhydramine
- Biological · Drug
- Lead sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- NIH
- Eligibility
- 18 Years and older
- Enrollment
- 290 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2015 – 2021
- U.S. locations
- 13
- States / cities
- Birmingham, Alabama • Los Angeles, California • San Francisco, California + 8 more
- Conditions
- Post-ERCP Pancreatitis
- Interventions
- Indomethacin, Placebo suppositories
- Drug · Other
- Lead sponsor
- University of Michigan
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 602 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2009 – 2011
- U.S. locations
- 4
- States / cities
- Indianapolis, Indiana • Lexington, Kentucky • Ann Arbor, Michigan + 1 more
- Conditions
- Premature Birth, Obstetric Labor, Premature
- Interventions
- Micronized progesterone suppository
- Drug
- Lead sponsor
- Washington University School of Medicine
- Other
- Eligibility
- 18 Years to 50 Years · Female only
- Enrollment
- 38 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2013 – 2018
- U.S. locations
- 1
- States / cities
- St Louis, Missouri
- Conditions
- Vulvodynia, Vestibulodynia, Vulvar Diseases, Vulvar Vestibulitis, Vulvar Pain
- Interventions
- BioNourish, a component of the Flourish HEC kit, Control - no intervention
- Device · Other
- Lead sponsor
- Vaginal Biome Science
- Other
- Eligibility
- 18 Years to 52 Years · Female only
- Enrollment
- 7 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2022 – 2024
- U.S. locations
- 1
- States / cities
- Virginia Beach, Virginia
- Conditions
- Bacterial Vaginosis
- Interventions
- Flourish HEC Vaginal Care System (contains a class II medical device plus other unregulated components)
- Device
- Lead sponsor
- Vaginal Biome Science
- Other
- Eligibility
- 18 Years to 52 Years · Female only
- Enrollment
- 6 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2021 – 2022
- U.S. locations
- 1
- States / cities
- Rosemont, Pennsylvania
- Conditions
- Infant, Premature, Premature Birth
- Interventions
- Intramuscular Progesterone, Vaginal Progesterone
- Drug
- Lead sponsor
- University of Oklahoma
- Other
- Eligibility
- 18 Years to 45 Years · Female only
- Enrollment
- 174 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2006 – 2011
- U.S. locations
- 1
- States / cities
- Oklahoma City, Oklahoma
- Conditions
- Healthy Volunteers
- Interventions
- Leuprolide Acetate 3.75, Estradiol, Progesterone, Placebo suppository, Placebo patch
- Drug
- Lead sponsor
- National Institute of Mental Health (NIMH)
- NIH
- Eligibility
- 18 Years to 50 Years · Female only
- Enrollment
- 100 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 1994 – 2020
- U.S. locations
- 1
- States / cities
- Bethesda, Maryland
- Conditions
- Metastatic Soft-tissue Sarcoma
- Interventions
- NOX66, Doxorubicin
- Drug
- Lead sponsor
- Noxopharm Limited
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 9 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2022 – 2023
- U.S. locations
- 4
- States / cities
- Duarte, California • Jacksonville, Florida • Rochester, Minnesota + 1 more
- Conditions
- Pelvic Organ Prolapse, Prolapse
- Interventions
- Reia System, Standard of Care Pessary
- Device
- Lead sponsor
- Medstar Health Research Institute
- Other
- Eligibility
- 18 Years and older · Female only
- Enrollment
- 218 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2024 – 2027
- U.S. locations
- 9
- States / cities
- Birmingham, Alabama • Palo Alto, California • Washington D.C., District of Columbia + 6 more
- Conditions
- Anal Dysplasia, Human Papilloma Virus, HIV
- Interventions
- imiquimod, ablative
- Drug · Procedure
- Lead sponsor
- United States Naval Medical Center, San Diego
- Federal
- Eligibility
- 18 Years and older · Male only
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2015 – 2016
- U.S. locations
- 1
- States / cities
- San Diego, California
- Conditions
- Constipation
- Interventions
- Senna Tab, Dulcolax Suppositories
- Dietary Supplement
- Lead sponsor
- Wake Forest University Health Sciences
- Other
- Eligibility
- 18 Years and older · Female only
- Enrollment
- 88 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2024 – 2027
- U.S. locations
- 1
- States / cities
- Winston-Salem, North Carolina
- Conditions
- Dysmenorrhea, Menstrual Pain
- Interventions
- Sildenafil citrate vaginal suppository, Placebo vaginal suppository
- Drug
- Lead sponsor
- Kevin Hellman
- Other
- Eligibility
- 18 Years to 35 Years · Female only
- Enrollment
- 50 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2026 – 2027
- U.S. locations
- 1
- States / cities
- Evanston, Illinois
- Conditions
- Vaginal Vault Prolapse, Pelvic Organ Prolapse, Uterine Prolapse, Pelvic Floor Prolapse
- Interventions
- Preoperative Pessary Use
- Device
- Lead sponsor
- Mayo Clinic
- Other
- Eligibility
- 18 Years and older · Female only
- Enrollment
- 58 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2016 – 2019
- U.S. locations
- 1
- States / cities
- Rochester, Minnesota
- Conditions
- Premenstrual Syndrome, Menstruation Disturbances
- Interventions
- Leuprolide, Estradiol Patches, Progesterone, Placebo patch, Placebo injection, Placebo suppository
- Drug
- Lead sponsor
- National Institute of Mental Health (NIMH)
- NIH
- Eligibility
- 18 Years to 45 Years · Female only
- Enrollment
- 60 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 1992 – 2020
- U.S. locations
- 1
- States / cities
- Bethesda, Maryland
- Conditions
- Vaginosis, Vaginosis, Bacterial, Vaginal Discharge
- Interventions
- Estrogen vaginal cream, Trimo-San vaginal gel
- Drug
- Lead sponsor
- The University of Texas Health Science Center, Houston
- Other
- Eligibility
- 40 Years and older · Female only
- Enrollment
- 4 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2019 – 2021
- U.S. locations
- 1
- States / cities
- Houston, Texas
- Conditions
- Vaginal Personal Care
- Interventions
- VH-01 vaginal suppository tablet, Placebo vaginal suppository tablet
- Other
- Lead sponsor
- Seed Health
- Industry
- Eligibility
- 18 Years and older · Female only
- Enrollment
- 200 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2024
- U.S. locations
- 1
- States / cities
- Santa Monica, California
- Conditions
- Encopresis, Autistic Disorder
- Interventions
- Glycerin Suppository, Bisacodyl suppository, Senna
- Drug
- Lead sponsor
- Emory University
- Other
- Eligibility
- 5 Years to 21 Years
- Enrollment
- 22 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2015 – 2017
- U.S. locations
- 1
- States / cities
- Atlanta, Georgia
- Conditions
- Neovaginal Microbiome
- Interventions
- Flourish Vaginal Care system
- Device
- Lead sponsor
- Vaginal Biome Science
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 56 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2022 – 2024
- U.S. locations
- 1
- States / cities
- New Hope, Pennsylvania
- Conditions
- Abortion, Second Trimester
- Interventions
- Vaginal Misoprostol, Buccal Misoprostol
- Drug
- Lead sponsor
- Virginia Commonwealth University
- Other
- Eligibility
- 18 Years to 50 Years · Female only
- Enrollment
- 70 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2016 – 2017
- U.S. locations
- 1
- States / cities
- Richmond, Virginia
- Conditions
- Preterm Labor, Preterm Birth
- Interventions
- Multimodal intervention strategy
- Other
- Lead sponsor
- Sera Prognostics, Inc.
- Industry
- Eligibility
- 18 Years and older · Female only
- Enrollment
- 6,500 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2020 – 2026
- U.S. locations
- 18
- States / cities
- San Diego, California • New Haven, Connecticut • Newark, Delaware + 15 more
- Conditions
- Pelvic Organ Prolapse, Inflammatory Response, Dysbiosis
- Interventions
- BiopHreshTM vaginal probiotic supplement (Good Clean Love, Inc. Eugene, OR) and RestoreTM gel., Standard Care
- Other
- Lead sponsor
- Hartford Hospital
- Other
- Eligibility
- 18 Years to 89 Years · Female only
- Enrollment
- 141 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2019 – 2021
- U.S. locations
- 1
- States / cities
- Hartford, Connecticut
- Conditions
- Encopresis, Autism Spectrum Disorder
- Interventions
- MIE Treatment, Glycerin Suppository, Treatment as Usual (TAU)
- Behavioral · Drug · Combination Product
- Lead sponsor
- Emory University
- Other
- Eligibility
- 5 Years to 12 Years
- Enrollment
- 117 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2017 – 2022
- U.S. locations
- 1
- States / cities
- Atlanta, Georgia